Staging and current treatment of hepatocellular carcinoma
- PMID: 16227495
- DOI: 10.1148/rg.25si055507
Staging and current treatment of hepatocellular carcinoma
Abstract
Early-stage hepatocellular carcinoma (HCC) is typically clinically silent, and HCC is often advanced at first manifestation. Without treatment, the 5-year survival rate is less than 5%. The selected treatment depends on the presence of comorbidity; tumor size, location, and morphology; and the presence of metastatic disease. Complete surgical resection followed by hepatic transplantation offers the best long-term survival, but few patients are eligible for this therapy. All other therapies are palliative. Radiofrequency ablation is the preferred method for managing unresectable small HCCs that are few in number. More widespread disease is treated with percutaneous therapies such as chemoembolization and selective internal radiation therapy. Systemic administration of biologic and chemotherapeutic agents is minimally successful in slowing the growth of HCC and typically is used to control symptoms in patients with overwhelming disease. A multidisciplinary approach that includes surgery, systemic therapy, and radiation therapy and that is based on the cooperation of radiation oncologists, interventional and diagnostic radiologists, hepatologists, and pathologists may offer the best chance of a cure or at least a longer and more normal life. To participate effectively in this effort, radiologists must be familiar with staging and treatment options for HCC and with the factors that affect the choice of management method.
Copyright RSNA, 2005.
Similar articles
-
[Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].Zhonghua Gan Zang Bing Za Zhi. 2012 Apr;20(4):256-60. doi: 10.3760/cma.j.issn.1007-3418.2012.04.006. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 22964144 Chinese.
-
Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center.Liver Transpl. 2004 Feb;10(2 Suppl 1):S98-106. doi: 10.1002/lt.20053. Liver Transpl. 2004. PMID: 14762848
-
Surgical resection and liver transplantation for hepatocellular carcinoma.Clin Liver Dis. 2015 May;19(2):381-99. doi: 10.1016/j.cld.2015.01.007. Epub 2015 Mar 2. Clin Liver Dis. 2015. PMID: 25921669 Review.
-
Preoperative TNM staging of hepatocellular carcinoma in hepatic transplantation: value of lipiodol computed tomography.Transplant Proc. 1995 Aug;27(4):2309-10. Transplant Proc. 1995. PMID: 7652821 No abstract available.
-
Management of Hepatocellular Carcinoma: Current Status and Future Directions.Gut Liver. 2015 Jul;9(4):437-48. doi: 10.5009/gnl15022. Gut Liver. 2015. PMID: 26087860 Free PMC article. Review.
Cited by
-
Prototype metal artefact reduction algorithm in flat panel computed tomography - evaluation in patients undergoing transarterial hepatic radioembolisation.Eur Radiol. 2018 Jan;28(1):265-273. doi: 10.1007/s00330-017-4946-1. Epub 2017 Jul 14. Eur Radiol. 2018. PMID: 28710583
-
Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.Radiology. 2009 Dec;253(3):861-9. doi: 10.1148/radiol.2533081968. Epub 2009 Aug 25. Radiology. 2009. PMID: 19709994 Free PMC article.
-
Combinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review.Cancer Cell Int. 2018 Sep 10;18:133. doi: 10.1186/s12935-018-0624-x. eCollection 2018. Cancer Cell Int. 2018. PMID: 30214375 Free PMC article. Review.
-
Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.J Clin Oncol. 2010 Sep 1;28(25):3994-4005. doi: 10.1200/JCO.2010.28.7805. Epub 2010 Aug 2. J Clin Oncol. 2010. PMID: 20679622 Free PMC article.
-
Hepatocellular Carcinoma with Bone Metastases: Incidence, Prognostic Significance, and Management-Single-Center Experience.J Gastrointest Cancer. 2017 Dec;48(4):321-325. doi: 10.1007/s12029-017-9998-6. J Gastrointest Cancer. 2017. PMID: 28891006 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical